Collectively, these observations provide a more comprehensive understanding of ANXA1 function in cell apoptosis after OGD/R and strongly suggest that decreasing nuclear ANXA1 migration might be a useful therapeutic approach for treating ischemic stroke. The gene discussed is ANXA1; the disease is ischemic stroke.